Table of Contents Understanding treatment plateaus with GLP-1 therapy Common reasons progress slows Clinical strategies to restore momentum Long-term monitoring and patient engagement FAQ Understanding Treatment Plateaus With GLP-1 Therapy A treatment plateau with GLP-1 medications typically occurs after an initial period of rapid improvement
The associated expenditures have been substantial: in 2022, the total annual cost of diabetes was $412.9 billion, and obesity-related medical costs in the US were estimated to be nearly $173 billion in 2021
By recognizing how essential these large-diameter connections areand how vulnerable they can becomefacility teams can take targeted steps to control risks
MacPherson JC, Comhair SA, Erzurum SC, Klein DF, Lipscomb MF, et al: Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species
However, it has been shown to cause side effects in some patients
